I think with FY 18 Operational Highlights below, the price per share in the TO bid should've been higher and I think there will be a counter bid from other players sitting on the fence.
• New executive leadership team in place, with the skills and capability to leverage thestrength of our integrated platform
• Strong sales momentum which has continued into FY19 – 7.5% top line growth and4.9% like-for-like (LFL) sales growth
• Integrated sites delivering superior results
• 8.5% LFL sales growth
• 17 in-store vet clinics added: +15 Australia, +2 New Zealand
• 22% of retail stores now have an in-store clinic
• Strong and growing group loyalty program accounting for over 90% of retail sales
• Private label sales increased to over $115 M and private label food sales in Australiahave increased by 25%
• Lowered vet turnover and vacancy rates
• Online sales up 70% to over $20 M, driven by click & collect
Enjoy the ride
- Forums
- ASX - By Stock
- Ann: Greencross enters into Scheme Implementation Agreement
I think with FY 18 Operational Highlights below, the price per...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online